2.00 USD
▲-0.02+2.04%
2026-08-03
市值
$289.95M
市盈率
—
EPS
-0.46
股息率
—
52 周区间
1.30 – 2.79
成交量
352.54K
Beta
1.17
目标价
7.33
52W 低 1.3052W 高 2.79
价格走势
公司简介
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company’s technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners’ drug development efforts. Its OmniAb platform’s Biological Intelligence powers the immune systems of its proprietary and engineered transgenic anim...